Silencing Of PAI-1 Using Sirna-Lipid Nanoparticles Reduces Thrombosis And Prolongs Life Span In Murine Models
Our bodies have a delicate balance when it comes to blood clotting. A protein called PAI-1 (plasminogen activator inhibitor 1) plays a crucial role in this balance by preventing the breakdown of blood clots. While essential for stopping bleeding, too much PAI-1 can lead to an increased risk of dangerous blood clots, a condition known as thrombosis, and is also linked to aging and age-related diseases like obesity.
Researchers have developed an innovative approach to tackle this problem using tiny delivery vehicles called lipid nanoparticles. These nanoparticles carry small interfering RNA (siRNA), which are like molecular messengers that can “silence” or turn down the production of specific proteins. In this case, the siRNA is designed to target and reduce the amount of PAI-1 in the body.
In studies conducted with mice, a single dose of these PAI-1-silencing nanoparticles significantly reduced PAI-1 levels for an extended period without causing noticeable side effects. This reduction in PAI-1 proved highly effective in decreasing the formation of blood clots in both young and older mice. Remarkably, this treatment also extended the lifespan of mice in a model of accelerated aging. Furthermore, the nanoparticles helped normalize abnormally high PAI-1 levels often seen in conditions like obesity.
This breakthrough suggests a promising new strategy for preventing and treating conditions associated with excessive blood clotting and could potentially offer a way to mitigate some of the negative impacts of aging on our health.
Source: link to paper